FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Alvogen, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Levothyroxine Sodium submitted by Alvogen, Inc., resulting in updated labeling for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypothyroidism
• Thyroid Cancer

Drugs mentioned

• LEVOTHYROXINE SODIUM (levothyroxine sodium)

Snippet

SUPPL AP for LEVOTHYROXINE SODIUM (LEVOTHYROXINE SODIUM)